1. Kasozi S, Clark J, Doi SAR. Intermittent versus daily pulmonary tuberculosis treatment regimens: a meta-analysis. Clin Med Res. 2015;13(3–4):117–38.
2. Kirirabwa NS, Kimuli D, DeJene S, Nanziri C, Birabwa E, Okello DA, et al. Response to anti-tuberculosis treatment by people over age 60 in Kampala, Uganda. Yotebieng M, editor. PLOS ONE. 2018; 13(12):e0208390.
3. Santos LC. Review: The Molecular Basis of Resistance in <i>Mycobacterium tuberculosis</i>. Open J Med Microbiol. 2012;02(01):24–36.
4. Canada, Health Canada, Public Health Agency of Canada, Centre de la lutte contre les maladies transmissibles et les infections (Canada). Tuberculosis prevention and control in Canada - a federal framework for action. [Internet]. 2014 [cited 2017 Nov 1]. Available from:
http://epe.lac-bac.gc.ca/100/201/301/weekly_checklist/2014/internet/w14-25-U-E.html/collections/collection_2014/aspc-phac/HP40-89-2013-eng.pdf
5. Liu JJ, Yao HY, Liu EY. Analysis of factors affecting the epidemiology of tuberculosis in China. Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis. 2005 Apr;9(4):450–4.